Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin,2005,55(2):74-108.
[2]
Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development[J]. J Exp Med, 2006, 203(9): 2201-2213.
[3]
Miao Z, Luker KE, Summers BC, et al. CXCR7(RDC1)romotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature [J]. Proc Natl Acad Sci USA, 2007,104(40):15735-15740.
[4]
Balkwill F. Cancer and the chemokine network [J]. Nat Rev Cancer, 2004, 4(7): 540-550.
[5]
Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes [J]. J Biol Chem, 2005, 280(42): 35760-35766.
[6]
Wang J, Shiozawa Y, Wang Y, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer [J]. J Biol Chem, 2008, 283(7): 4283-4294.
[7]
Marechal R, Demetter P, Nagy N, et al. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma [J]. Br J Cancer, 2009, 100(9): 1444-1451.
[8]
Hou KL, Hao MG, Bo JJ, et al. CXCR7 in tumorigenesis and progression [J]. Ai Zheng, 2010, 29(4):456-459.
[9]
Grymula K,Tarnowski M,Wysoczynski M,et a1.Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas[J].Int J Cancer, 2010, 127: 2554-2568.
